Gepefrine

Gepefrine
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Gepefrine is a sympathomimetic drug that is used primarily for its vasoconstrictor and bronchodilator effects. It is a synthetic compound that mimics the effects of endogenous catecholamines such as epinephrine and norepinephrine.

Pharmacology

Gepefrine acts on the adrenergic receptors in the body, particularly the alpha and beta receptors. By stimulating these receptors, Gepefrine induces vasoconstriction, which leads to an increase in blood pressure. It also causes bronchodilation, making it useful in the treatment of conditions such as asthma and chronic obstructive pulmonary disease (COPD).

Mechanism of Action

Gepefrine works by binding to adrenergic receptors on the surface of cells. This binding activates the G protein-coupled receptor pathways, leading to an increase in intracellular cyclic adenosine monophosphate (cAMP) levels. The rise in cAMP results in the relaxation of smooth muscle cells in the bronchi and the contraction of smooth muscle cells in the blood vessels.

Clinical Uses

Gepefrine is used in the management of several medical conditions:

• As a bronchodilator in the treatment of asthma and COPD.
• As a vasopressor agent in the management of hypotension during anesthesia or shock.

Side Effects

Common side effects of Gepefrine include:

• Tachycardia
• Hypertension
• Anxiety
• Tremors

Administration

Gepefrine is typically administered via intravenous or intramuscular injection. The dosage and route of administration depend on the clinical condition being treated and the patient's response to the drug.

Related pages

• Sympathomimetic drug
• Adrenergic receptor
• Bronchodilator
• Vasoconstrictor

• 
  Gepefrine

• 
  Gepefrine